Skip to Content

Libmeldy 2-10 x 106 cells / mL dispersion for infusion

Licence status
Authorised: 17/12/2020
Active substances
Autologous CD34+ cell enriched population that contains hematopoietic stem and progenitor cells transduced ex vivo using a lentiviral vector encoding the Human Arylsulfatase a Gene
Dosage Form
Dispersion for infusion
Licence number
EU/1/20/1493/001
Licence holder
Orchard Therapeutics (Netherlands) B.V.

Licence information

ATC code
A16AB21 atidarsagene autotemcel
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
17/12/2020